Investors Purchase High Volume of Put Options on Amedisys (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED) saw some unusual options trading activity on Friday. Stock investors purchased 3,269 put options on the stock. This is an increase of 136% compared to the typical daily volume of 1,385 put options.

Amedisys Stock Up 4.7 %

Amedisys stock opened at $89.96 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a market cap of $2.95 billion, a P/E ratio of 35.70, a P/E/G ratio of 1.84 and a beta of 0.73. The business has a fifty day moving average of $90.45 and a two-hundred day moving average of $94.43. Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm had revenue of $587.67 million during the quarter, compared to analysts’ expectations of $586.75 million. During the same period in the prior year, the firm posted $0.98 earnings per share. Amedisys’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, analysts forecast that Amedisys will post 4.45 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Amedisys

Hedge funds have recently made changes to their positions in the company. Polar Asset Management Partners Inc. purchased a new stake in Amedisys during the 3rd quarter valued at about $28,953,000. SG Americas Securities LLC lifted its holdings in shares of Amedisys by 413.4% during the third quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after purchasing an additional 158,398 shares during the period. Verition Fund Management LLC increased its holdings in Amedisys by 608.1% in the 3rd quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock worth $11,077,000 after buying an additional 98,565 shares during the period. Westchester Capital Management LLC increased its holdings in Amedisys by 9.5% in the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock worth $107,976,000 after buying an additional 97,476 shares during the period. Finally, Highbridge Capital Management LLC increased its holdings in Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after buying an additional 83,200 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.